West Pharmaceutical Services, Inc. (WST)
364.98
-0.03
(-0.01%)
USD |
NYSE |
Oct 02, 16:00
364.75
-0.23
(-0.06%)
Pre-Market: 20:00
West Pharmaceutical Services Profit Margin (Quarterly) : 17.65% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.65% |
| March 31, 2026 | 16.43% |
| December 31, 2025 | 16.39% |
| September 30, 2025 | 17.41% |
| June 30, 2025 | 17.20% |
| March 31, 2025 | 12.86% |
| December 31, 2024 | 17.38% |
| September 30, 2024 | 18.21% |
| June 30, 2024 | 15.85% |
| March 31, 2024 | 16.58% |
| December 31, 2023 | 18.71% |
| September 30, 2023 | 21.58% |
| June 30, 2023 | 20.56% |
| March 31, 2023 | 19.56% |
| December 31, 2022 | 14.54% |
| September 30, 2022 | 17.57% |
| June 30, 2022 | 24.43% |
| March 31, 2022 | 24.15% |
| December 31, 2021 | 20.26% |
| September 30, 2021 | 24.85% |
| June 30, 2021 | 25.87% |
| March 31, 2021 | 22.53% |
| December 31, 2020 | 16.96% |
| September 30, 2020 | 15.01% |
| June 30, 2020 | 17.31% |
| Date | Value |
|---|---|
| March 31, 2020 | 15.12% |
| December 31, 2019 | 13.45% |
| September 30, 2019 | 12.35% |
| June 30, 2019 | 14.08% |
| March 31, 2019 | 12.50% |
| December 31, 2018 | 12.31% |
| September 30, 2018 | 12.79% |
| June 30, 2018 | 12.53% |
| March 31, 2018 | 10.48% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 12.79% |
| June 30, 2017 | 9.75% |
| March 31, 2017 | 15.70% |
| December 31, 2016 | 10.23% |
| September 30, 2016 | 9.98% |
| June 30, 2016 | 11.52% |
| March 31, 2016 | 6.10% |
| December 31, 2015 | 9.30% |
| September 30, 2015 | 0.44% |
| June 30, 2015 | 7.74% |
| March 31, 2015 | 9.80% |
| December 31, 2014 | 8.97% |
| September 30, 2014 | 8.71% |
| June 30, 2014 | 10.19% |
| March 31, 2014 | 7.81% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Globus Medical, Inc. | 19.20% |
| Veracyte, Inc. | 16.96% |
| Hinge Health, Inc. | 20.25% |
| The Cooper Cos., Inc. | 40.59% |
| Repligen Corp. | 2.45% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 18.66% |
| Return on Assets | 13.77% |
| Return on Invested Capital | 16.90% |
| Gross Profit Margin (Quarterly) | 37.83% |
| Operating Margin (Quarterly) | 22.73% |
| Return on Net Operating Assets | 18.60% |